amantadine has been researched along with gamma-aminobutyric acid in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (52.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Lazarova, MB; Roussinov, KS | 1 |
| Clark, WG; Menon, MK | 2 |
| Bigalke, H; Lampe, H | 1 |
| Vamvakidès, A | 2 |
| Otomo, E | 1 |
| Anami, K; Fukuda, T; Maruyama, Y; Morimoto, Y; Setoguchi, M; Usa, T | 1 |
| Soyka, D | 1 |
| Lazarova, M; Roussinov, K | 1 |
| Alphs, L; Davis, JM | 1 |
| Maj, J | 1 |
| Colucci d'Amato, C; Cristillo, A; Puccini, A; Vizioli, R | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| Maj, J; Sontag, KH; Wesemann, W | 1 |
| Ohtomo, E | 1 |
| Albuquerque, EX; Alkondon, M; Braga, MF; Matsubayashi, H; Pereira, EF | 1 |
| Koller, W; Marjama-Lyons, J | 1 |
| Arndt, T; Heimeroth, A; John, D; Mueller, HH; Oertel, WH; Reis, J; Rosenow, F | 1 |
| Storozhuk, VM; Zinyuk, LE | 1 |
| Bido, S; Marti, M; Morari, M | 1 |
| Mamie, C | 1 |
| Amato, L; Amin-Esmaeili, M; Gholami, J; Hoseinie, L; Rahimi-Movaghar, A; Yousefi-Nooraie, R | 1 |
| Garg, C; Garg, M; Walia, V | 1 |
8 review(s) available for amantadine and gamma-aminobutyric acid
| Article | Year |
|---|---|
[Action mechanism of adamantamines: do their activity on glutamatergic receptors intervene in the expression of their pharmacological profile?].
Topics: Amantadine; Antibodies; Antiparkinson Agents; gamma-Aminobutyric Acid; Glycine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 1991 |
[Are there glutamatergic, anti-GABAergic or antiglycinergic components in the action mechanism of adamantamines? Study of convulsions induced by amantadine or 1-adamantylcyclopentanamine in mice].
Topics: Amantadine; Animals; Convulsants; GABA Antagonists; gamma-Aminobutyric Acid; Glutamates; Glycine; Male; Mice; Mice, Inbred BALB C; Seizures | 1990 |
[Biochemical bases of Parkinson disease].
Topics: Acetylcholine; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dopa Decarboxylase; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Selegiline; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 1984 |
[Pharmacodynamics and pharmacokinetics of memantine].
Topics: Amantadine; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dopamine; Dyskinesia, Drug-Induced; Electrophysiology; gamma-Aminobutyric Acid; Guinea Pigs; Hemodynamics; Humans; Kinetics; Memantine; Mice; Motor Activity; Norepinephrine; Rabbits; Rats; Respiration; Stereotyped Behavior | 1983 |
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Ergolines; gamma-Aminobutyric Acid; Humans; Lisuride; Memory Disorders; Mice; Pantothenic Acid | 1984 |
Tremor-predominant Parkinson's disease. Approaches to treatment.
Topics: Acetates; Amantadine; Amines; Antiparkinson Agents; Botulinum Toxins; Cholinergic Antagonists; Clonazepam; Clozapine; Cyclohexanecarboxylic Acids; Dopamine Agonists; Electric Stimulation Therapy; Gabapentin; Gamma Rays; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Neurosurgical Procedures; Parkinson Disease; Propranolol; Radiosurgery; Thalamus; Tremor | 2000 |
[Prevention of postoperative hyperalgesia].
Topics: Amantadine; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperalgesia; Ketamine; Magnesium Compounds; Pain Management; Pain, Postoperative; Receptors, N-Methyl-D-Aspartate; Risk Assessment | 2012 |
Pharmacological therapies for management of opium withdrawal.
Topics: Amantadine; Amines; Baclofen; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Methadone; Opioid-Related Disorders; Opium; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2018 |
2 trial(s) available for amantadine and gamma-aminobutyric acid
| Article | Year |
|---|---|
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Ergolines; gamma-Aminobutyric Acid; Humans; Lisuride; Memory Disorders; Mice; Pantothenic Acid | 1984 |
Modulation of human motor cortex excitability by single doses of amantadine.
Topics: Adult; Amantadine; Antiparkinson Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Efferent Pathways; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Motor Cortex; Muscle, Skeletal; Neural Inhibition; Neural Pathways; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Transcranial Magnetic Stimulation | 2006 |
16 other study(ies) available for amantadine and gamma-aminobutyric acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Apomorphine; Dextroamphetamine; Ditiocarb; Dopamine; Drug Interactions; gamma-Aminobutyric Acid; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Seizures | 1978 |
GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145).
Topics: Amantadine; Aminooxyacetic Acid; Animals; Dextroamphetamine; gamma-Aminobutyric Acid; Memantine; Mice; Motor Activity; Time Factors | 1979 |
Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145).
Topics: Amantadine; Aminooxyacetic Acid; Animals; Dextroamphetamine; Drug Interactions; gamma-Aminobutyric Acid; Male; Memantine; Methyltyrosines; Mice; Motor Activity; Phenoxybenzamine; Reserpine | 1978 |
Modulation of glycine-activated membrane current by adamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Cell Membrane; Cells, Cultured; Chloride Channels; Fetus; gamma-Aminobutyric Acid; Glycine; Ion Channels; Membrane Potentials; Membrane Proteins; Mice; Neurons; Spinal Cord | 1991 |
[Drug therapy of Alzheimer's disease. General concepts on nootropic drugs].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Aminoacridines; Dementia; gamma-Aminobutyric Acid; Humans; Pantothenic Acid; Tacrine | 1988 |
[Pharmacological studies on Y-8894. (III). Its effect on the abnormal electrocorticogram induced by destruction of the internal capsule].
Topics: Amantadine; Animals; Cerebral Cortex; Delta Rhythm; Electroencephalography; gamma-Aminobutyric Acid; Imipramine; Male; Morpholines; Pantothenic Acid; Rats; Rats, Inbred Lew; Theta Rhythm | 1986 |
[Syndrome involving the extrapyramidal motor systems and their drug treatment].
Topics: Amantadine; Antiparkinson Agents; Basal Ganglia Diseases; Dihydroxyphenylalanine; gamma-Aminobutyric Acid; Humans; Hyperkinesis; Myoclonus; Parasympatholytics; Parkinson Disease; Penicillamine; Syndrome; Tranquilizing Agents | 1974 |
Role of the relationships between the neurotransmitter systems in the convulsive-seizure reactions.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Dopamine; Electroshock; gamma-Aminobutyric Acid; Kindling, Neurologic; Levodopa; Mice; Neurotransmitter Agents; Rats; Seizures; Serotonin | 1982 |
Noncatecholaminergic treatments of tardive dyskinesia.
Topics: Amantadine; Anti-Anxiety Agents; Benzodiazepines; Cyproheptadine; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Double-Blind Method; Dyskinesia, Drug-Induced; Enkephalin, Methionine; gamma-Aminobutyric Acid; Humans; Lithium; Parasympathomimetics; Phenytoin; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, GABA-A; Substance Withdrawal Syndrome; Tryptophan | 1982 |
[Effect of memantine on central neurotransmitter systems. Review of the results].
Topics: Acetylcholine; Amantadine; Animals; Blood Pressure; Catalepsy; Central Nervous System; gamma-Aminobutyric Acid; Humans; Memantine; Motor Activity; Neurotransmitter Agents; Rats; Receptors, Dopamine; Receptors, Serotonin; Rotation; Stereotyped Behavior; Temperature | 1982 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine.
Topics: Amantadine; Animals; Cells, Cultured; gamma-Aminobutyric Acid; Hippocampus; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Strychnine; Synapses | 1998 |
Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine.
Topics: Action Potentials; Amantadine; Animals; Behavior, Animal; Cats; Conditioning, Classical; Dopamine; Dopamine Agents; Electric Stimulation; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Movement; N-Methylaspartate; Neurons; Reaction Time; Somatosensory Cortex; Sulpiride; Wakefulness | 2007 |
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.
Topics: Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Data Interpretation, Statistical; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Globus Pallidus; Glutamates; Hydroxydopamines; Levodopa; Male; Mice; Microdialysis; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2011 |
Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways.
Topics: Amantadine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Nitric Oxide; Nitrites; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2020 |